
Chinese pharmaceutical group established on 13 January 2004 in the Shahe industrial park of Zhanggong district, Ganzhou, Jiangxi with 200 million yuan of registered capital. Combines industry, academia and research with manufacturing and trade across ten wholly owned subsidiaries, two controlled companies and one associate in Ganzhou, Beijing, Shanghai, Hangzhou, Shenzhen and Kunming, employing more than 2,000 people. Invests over a tenth of sales in research each year and runs chemical innovative drug, high value generic, innovative natural medicine and pilot-scale translation platforms in Shanghai, Beijing, Hangzhou and Ganzhou with more than sixty products in development. Recognised as a high-tech enterprise, one of Jiangxi's top ten pharmaceutical companies and a Jiangxi science and technology innovation leader, and among China's top hundred pharmaceutical manufacturers since 2012.
Deja tu valoración